 | • レポートコード：TPM-B04589 • 出版社/出版日：Transparency Market Research / 2018年3月28日 • レポート形態：英文、PDF、222ページ • 納品方法：Eメール • 産業分類：製薬・医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、遺伝子デリバリーシステムの世界市場について調べ、遺伝子デリバリーシステムの世界規模、市場動向、市場環境、デリバリーシステム別（ウイルス遺伝子デリバリー、非ウイルス性遺伝子デリバリー、組合・ハイブリッドシステム）分析、用途別（感染症、腫瘍、眼科、泌尿器科、糖尿病、CNS）分析、投与経路別（経口、注射、吸入、経皮、経眼、経鼻、局所）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・遺伝子デリバリーシステムの世界市場動向 ・遺伝子デリバリーシステムの世界市場環境 ・遺伝子デリバリーシステムの世界市場規模 ・遺伝子デリバリーシステムの世界市場規模：デリバリーシステム別（ウイルス遺伝子デリバリー、非ウイルス性遺伝子デリバリー、組合・ハイブリッドシステム） ・遺伝子デリバリーシステムの世界市場規模：用途別（感染症、腫瘍、眼科、泌尿器科、糖尿病、CNS） ・遺伝子デリバリーシステムの世界市場規模：投与経路別（経口、注射、吸入、経皮、経眼、経鼻、局所） ・遺伝子デリバリーシステムの世界市場：地域別市場規模・分析 ・遺伝子デリバリーシステムの北米市場規模・予測 ・遺伝子デリバリーシステムのアメリカ市場規模・予測 ・遺伝子デリバリーシステムの中南米市場規模・予測 ・遺伝子デリバリーシステムのヨーロッパ市場規模・予測 ・遺伝子デリバリーシステムのアジア市場規模・予測 ・遺伝子デリバリーシステムの日本市場規模・予測 ・遺伝子デリバリーシステムの中国市場規模・予測 ・遺伝子デリバリーシステムのインド市場規模・予測 ・遺伝子デリバリーシステムの中東市場規模・予測 ・遺伝子デリバリーシステムのアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Gene Delivery System Market: Overview
This report analyzes the current and future scenario of the global the global gene delivery system market. Rise in investments for R&D of novel advanced technologies, increase in incidences of chronic diseases such as cancer, surge in demand for gene therapy, and rise in awareness regarding treatment options expected to drive the market. Gene delivery systems are used to deliver therapeutic drugs to a targeted area. Gene delivery is a procedure to introduce foreign DNA into host cells. The global gene delivery system market is segmented according to type of delivery system, application, route of administration, and geography.
The global gene delivery system market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also offers data analysis of the global market with respect to the segments based on type of delivery system, application, route of administration, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. Moreover, the section comprises competitive matrix and company profiles with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global gene delivery system market.
Global Gene Delivery System Market: Key Segments
Based on delivery system the global gene delivery system market is segmented into viral gene delivery system, non-viral gene delivery system, and combined hybrid system. The viral gene delivery system is further classified into adenovirus system, lentivirus vector, retrovirus vector, adeno-associated virus vector, sendai virus vector, herpes simplex virus vector, and others. The non-viral gene delivery system is further divide into natural organic compounds, physical methods, and chemical methods. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Based on application, the global gene delivery system market is segmented into infectious diseases, oncology, ophthalmology, urology, diabetes, CNS, and others. The oncology segment dominates the market. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
In terms of route of administration, the global gene delivery system market is segmented into oral, injectable, inhalation, transdermal, ocular, nasal, topical, and others. The injectable segment dominates the market. The market size and forecast for each of these segments have been provided for the period between 2015 and 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.
Global Gene Delivery System Market: Regional Outlook
Based on geography, the global gene delivery system market has been categorized into five major regions and key countries in the respective regions: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.
Companies Mentioned in Report
The report also profiles major players operating in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the global gene delivery system market are Novartis AG, Amgen Inc., Oxford BioMedia plc, SIBIONO, Shanghai Sunway Biotech Co. Ltd., Pfizer Inc., Bayer AG, Johnson & Johnson Services Inc., Human Stem Cells Institute, and Epeius Biotechnologies Corporation.
The global gene delivery system market has been segmented as follows:
Gene Delivery System Market, by Delivery System
Viral Gene Delivery
Adenovirus Vector
Lentivirus Vector
Retrovirus Vector
Adeno-associated Virus Vector
Sendai Virus Vector
Herpes Simplex Virus Vector
Others
Non-viral Gene Delivery
Natural Organic Compounds
Physical Methods
Chemical Methods
Combined Hybrid Delivery System
Gene Delivery System Market, by Application
Infectious Diseasess
Oncology
Ophthalmology
Urology
Diabetes
CNS
Others
Gene Delivery System Market, by Route of Administration
Oral
Injectable
Inhalation
Transdermal
Ocular
Nasal
Topical
Gene Delivery System Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
Japan
China
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
Israel
South Africa
Rest of MEA
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Gene Delivery System Market
4. Market Overview
4.1. Introduction
4.1.1. Delivery System Definition
4.2. Overview
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Gene Delivery System Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Market Outlook
4.8. Technological Advancements in Gene Delivery Products
4.9. Regulatory Scenario
4.10. Gene Therapy Pipeline Molecules
5. Global Gene Delivery System Market Analysis and Forecasts, by Delivery System
5.1. Introduction & Definition
5.2. Key Findings
5.4. Market Value Forecast by Delivery System, 2015–2025
5.4.1. Viral Gene Delivery
5.4.1.1. Adenovirus Vector
5.4.1.2. Lentivirus Vector
5.4.1.3. Retrovirus Vector
5.4.1.4. Adeno-associated Virus Vector
5.4.1.5. Sendai Virus Vector
5.4.1.6. Herpes Simplex Virus Vector
5.4.1.7. Others
5.4.2. Non-viral Gene Delivery
5.4.2.1. Natural Organic Compounds
5.4.2.2. Physical Methods
5.4.2.3. Chemical Methods
5.4.3. Combined Hybrid Delivery System
5.5. Market Attractiveness by Delivery System
6. Global Gene Delivery System Market Analysis and Forecasts, by Application
6.1. Introduction & Definition
6.2. Key Findings
6.4. Market Value Forecast by Application, 2015–2025
6.4.1. Infectious Diseases
6.4.2. Oncology
6.4.3. Ophthalmology
6.4.4. Urology
6.4.5. Diabetes
6.4.6. CNS
6.4.7. Others
6.5. Market Attractiveness by Application
7. Global Gene Delivery System Market Analysis and Forecasts, by Route of Administration
7.1. Introduction & Definition
7.2. Key Findings
7.4. Market Value Forecast by Route of Administration, 2015–2025
7.4.1. Oral
7.4.2. Injectable
7.4.3. Inhalation
7.4.4. Transdermal
7.4.5. Ocular
7.4.6. Nasal
7.4.7. Topical
7.5. Market Attractiveness by Route of Administration
8. Global Gene Delivery System Market Analysis and Forecasts, by Region
8.1. Key Findings
8.2. Market Value Forecast by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness by Region
9. North America Gene Delivery System Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast by Delivery System, 2015–2025
9.2.1. Viral Gene Delivery
9.2.1.1. Adenovirus Vector
9.2.1.2. Lentivirus Vector
9.2.1.3. Retrovirus Vector
9.2.1.4. Adeno-associated Virus Vector
9.2.1.5. Sendai Virus Vector
9.2.1.6. Herpes Simplex Virus Vector
9.2.1.7. Others
9.2.2. Non-viral Gene Delivery
9.2.2.1. Natural Organic Compounds
9.2.2.2. Physical Methods
9.2.2.3. Chemical Methods
9.2.3. Combined Hybrid Delivery System
9.3. Market Value Forecast by Application, 2015–2025
9.3.1. Infectious Diseases
9.3.2. Oncology
9.3.3. Ophthalmology
9.3.4. Urology
9.3.5. Diabetes
9.3.6. CNS
9.3.7. Others
9.4. Market Value Forecast by Route of Administration, 2015–2025
9.4.1. Oral
9.4.2. Injectable
9.4.3. Inhalation
9.4.4. Transdermal
9.4.5. Ocular
9.4.6. Nasal
9.4.7. Topical
9.5. Market Value Forecast by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. by Delivery System
9.6.2. by Application
9.6.3. by Route of Administration
9.6.4. by Country
10. Europe Gene Delivery System Market Analysis and Forecast
10.1.Introduction
10.1.1. Key Findings
10.2.Market Value Forecast by Delivery System, 2015–2025
10.2.1. Viral Gene Delivery
10.2.1.1. Adenovirus Vector
10.2.1.2. Lentivirus Vector
10.2.1.3. Retrovirus Vector
10.2.1.4. Adeno-associated Virus Vector
10.2.1.5. Sendai Virus Vector
10.2.1.6. Herpes Simplex Virus Vector
10.2.1.7. Others
10.2.2. Non-viral Gene Delivery
10.2.2.1. Natural Organic Compounds
10.2.2.2. Physical Methods
10.2.2.3. Chemical Methods
10.2.3. Combined Hybrid Delivery System
10.3.Market Value Forecast by Application, 2015–2025
10.3.1. Infectious Diseases
10.3.2. Oncology
10.3.3. Ophthalmology
10.3.4. Urology
10.3.5. Diabetes
10.3.6. CNS
10.3.7. Others
10.4.Market Value Forecast by Route of Administration, 2015–2025
10.4.1. Oral
10.4.2. Injectable
10.4.3. Inhalation
10.4.4. Transdermal
10.4.5. Ocular
10.4.6. Nasal
10.4.7. Topical
10.5.Market Value Forecast by Country/Sub-region, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6.Market Attractiveness Analysis
10.6.1. by Delivery System
10.6.2. by Application
10.6.3. by Route of Administration
10.6.4. by Country/Sub-region
11. Asia Pacific Gene Delivery System Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast by Delivery System, 2015–2025
11.2.1. Viral Gene Delivery
11.2.1.1. Adenovirus Vector
11.2.1.2. Lentivirus Vector
11.2.1.3. Retrovirus Vector
11.2.1.4. Adeno-associated Virus Vector
11.2.1.5. Sendai Virus Vector
11.2.1.6. Herpes Simplex Virus Vector
11.2.1.7. Others
11.2.2. Non-viral Gene Delivery
11.2.2.1. Natural Organic Compounds
11.2.2.2. Physical Methods
11.2.2.3. Chemical Methods
11.2.3. Combined Hybrid Delivery System
11.3.Market Value Forecast by Application, 2015–2025
11.3.1. Infectious Diseases
11.3.2. Oncology
11.3.3. Ophthalmology
11.3.4. Urology
11.3.5. Diabetes
11.3.6. CNS
11.3.7. Others
11.4.Market Value Forecast by Route of Administration, 2015–2025
11.4.1. Oral
11.4.2. Injectable
11.4.3. Inhalation
11.4.4. Transdermal
11.4.5. Ocular
11.4.6. Nasal
11.4.7. Topical
11.5.Market Value Forecast by Country/Sub-region, 2015–2025
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Australia and New Zealand
11.5.5. Rest of Asia Pacific
11.6.Market Attractiveness Analysis
11.6.1. by Delivery System
11.6.2. by Application
11.6.3. by Route of Administration
11.6.4. by Country
12. Latin America Gene Delivery System Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast by Delivery System, 2015–2025
12.2.1. Viral Gene Delivery
12.2.1.1. Adenovirus Vector
12.2.1.2. Lentivirus Vector
12.2.1.3. Retrovirus Vector
12.2.1.4. Adeno-associated Virus Vector
12.2.1.5. Sendai Virus Vector
12.2.1.6. Herpes Simplex Virus Vector
12.2.1.7. Others
12.2.2. Non-viral Gene Delivery
12.2.2.1. Natural Organic Compounds
12.2.2.2. Physical Methods
12.2.2.3. Chemical Methods
12.2.3. Combined Hybrid Delivery System
12.3.Market Value Forecast by Application, 2015–2025
12.3.1. Infectious Diseases
12.3.2. Oncology
12.3.3. Ophthalmology
12.3.4. Urology
12.3.5. Diabetes
12.3.6. CNS
12.3.7. Others
12.4.Market Value Forecast by Route of Administration, 2015–2025
12.4.1. Oral
12.4.2. Injectable
12.4.3. Inhalation
12.4.4. Transdermal
12.4.5. Ocular
12.4.6. Nasal
12.4.7. Topical
12.5.Market Value Forecast by Country/Sub-region, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6.Market Attractiveness Analysis
12.6.1. by Delivery System
12.6.2. by Application
12.6.3. by Route of Administration
12.6.4. by Country/Sub-region
13. Middle East & Africa Gene Delivery System Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast by Delivery System, 2015–2025
13.2.1. Viral Gene Delivery
13.2.1.1. Adenovirus Vector
13.2.1.2. Lentivirus Vector
13.2.1.3. Retrovirus Vector
13.2.1.4. Adeno-associated Virus Vector
13.2.1.5. Sendai Virus Vector
13.2.1.6. Herpes Simplex Virus Vector
13.2.1.7. Others
13.2.2. Non-viral Gene Delivery
13.2.2.1. Natural Organic Compounds
13.2.2.2. Physical Methods
13.2.2.3. Chemical Methods
13.2.3. Combined Hybrid Delivery System
13.3.Market Value Forecast by Application, 2015–2025
13.3.1. Infectious Diseases
13.3.2. Oncology
13.3.3. Ophthalmology
13.3.4. Urology
13.3.5. Diabetes
13.3.6. CNS
13.3.7. Others
13.4.Market Value Forecast by Route of Administration, 2015–2025
13.4.1. Oral
13.4.2. Injectable
13.4.3. Inhalation
13.4.4. Transdermal
13.4.5. Ocular
13.4.6. Nasal
13.4.7. Topical
13.5.Market Value Forecast by Country/Sub-region, 2015–2025
13.5.1. South Africa
13.5.2. UAE
13.5.3. Saudi Arabia
13.5.4. Rest of Middle East & Africa
13.6.Market Attractiveness Analysis
13.6.1. by Delivery System
13.6.2. by Application
13.6.3. by Route of Administration
13.6.4. by Country/Sub-region
14. Competition Landscape
14.1.Market Player – Competition Matrix (by Tier and Size of Companies)
14.2.Market Share Analysis by Company (2016)
14.3.Company Profiles (Overview, Financials, Recent Developments, Strategy)
14.3.1. Novartis AG
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Amgen Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Oxford BioMedia plc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. SIBIONO
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Shanghai Sunway Biotech Co. Ltd.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Pfizer Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Bayer AG
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Johnson & Johnson Services Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Human Stem Cells Institute
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Epeius Biotechnologies Corporation
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Financial Overview
14.3.10.3. Product Portfolio
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
Table 01: Regulatory Scenario in Different Countries
Table 02: Gene Therapy Pipeline Molecules
Table 03: Drug Therapy Pipeline Products
Table 04: Global Gene Delivery Systems Market Size (US$ Mn) Forecast, by Delivery System, 2015–2025
Table 05: Global Gene Delivery Systems Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 06: Global Gene Delivery Systems Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 07: Global Gene Delivery System Market Value (US$ Mn) Forecast, by Application, 2015–2025
Table 08: Global Gene Delivery Systems Market Value (US$ Mn) Forecast, by Route of Administration, 2015–2025
Table 09: Global Gene Delivery System Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 10: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 11: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Delivery System, 2015–2025
Table 12: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 13: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 14: North America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 15: North America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 16: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 17: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Delivery System, 2015–2025
Table 18: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 19: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 20: Europe Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 21: Europe Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 22: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 23: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Delivery System, 2015–2025
Table 24: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 25: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 26: Asia Pacific Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 27: Asia Pacific Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 28: Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 29: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Delivery System, 2015–2025
Table 30: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025
Table 31: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 32: Latin America Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 33: Latin America Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025
Table 34: Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Country/Sub-region, 2015–2025
Table 35: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Delivery System, 2015–2025
Table 36: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Viral Gene Delivery, 2015–2025, 2015–2025
Table 37: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Non-viral Gene Delivery, 2015–2025
Table 38: Middle East & Africa Gene Delivery System Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 39: Middle East & Africa Gene Delivery System Market Size (US$ Bn) Forecast, by Route of Administration, 2015–2025